#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Sandra Spalek"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/a5b84013a08880975ca84f40999e4404b14a97e2/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

# Add statements below this comment

SET Citation = {"PubMed","18930136"}

SET Evidence = "Considering the importance of protein catabolism in maintaining cell homeostasis,
it is not surprising that dysregulation of protein turnover is associated with myriad disease
states such as cancer and neurodegeneration [5]."
bp(GO:"cellular protein catabolic process") reg bp(GO:"cellular homeostasis")
bp(GO:"cellular protein catabolic process") neg path(MESH:Neoplasms)
bp(GO:"cellular protein catabolic process") neg path(HBP:Neurodegeneration)

SET Evidence = "UPS-mediated catabolism is also essential to mainten amino acid pools in acute starvation
and contributes significantly to the degradation of defective proteins [1,2,7]."
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") reg bp(GO:"amino acid homeostasis")
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -> bp(GO:"cellular protein catabolic process")

SET Evidence = "Autophagy, by contrast, is primarily responsible for degrading long-lived proteins and maintaining amino acid
pools in the setting of chronic starvation, although its contribution to the degradation of
defective proteins may equal that of the UPS."
bp(GO:autophagy) -> bp(GO:"cellular protein catabolic process")
bp(GO:autophagy) reg bp(GO:"amino acid homeostasis")

SET Evidence = "“Autophagy”, literally “self-eating”, describes a catabolic process in which cell constituents
such as organelles and proteins are delivered to the lysosomal compartment for degradation."
bp(GO:autophagy) -> tloc(a(GO:organelle),fromLoc(GO:cytoplasm),toLoc(GO:lysosome))
bp(GO:autophagy) -> tloc(a(MESH:Proteins),fromLoc(GO:cytoplasm),toLoc(GO:lysosome))
SET CellStructure = "Lysosomes"
bp(GO:autophagy) -> deg(a(GO:organelle))
bp(GO:autophagy) -> deg(a(MESH:Proteins))
UNSET CellStructure

SET Evidence = "Autophagy is an evolutionarily conserved process whose primary task in lower organisms is
the maintenance of metabolic homeostasis in the face of changing nutrient availability [8]."
bp(GO:autophagy) reg bp(GO:"metabolic process")

SET Evidence = "This role in recycling is complementary to that of the UPS, which degrades proteins to generate
oligopeptides that are subsequently degraded into amino acids while replenishing the cell’s supply of free ubiquitin."
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -> rxn(reactants(a(MESH:Proteins)),products(a(CHEBI:oligopeptide)))
deg(a(CHEBI:oligopeptide)) -> a(CHEBI:"amino acid")
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -> bp(GO:"ubiquitin recycling")

SET Evidence = "Recent advances have demonstrated that autophagy also serves a
surprisingly diverse array of additional functions, including organelle clearance, antigen
presentation, elimination of microbes, as well as regulation of development and cell death [9]."
bp(GO:autophagy) -> deg(a(GO:organelle))
bp(GO:autophagy) -- bp(GO:"antigen processing and presentation")
bp(GO:autophagy) -| bp(MESH:Microbiota)
bp(GO:autophagy) reg bp(GO:"cell death")

SET Evidence = "Microautophagy consists of direct engulfment of small volumes of cytosol by lysosomes
[10], whereas chaperone-mediated autophagy (CMA) involves selective, receptor-mediated
translocation of proteins into the lysosomal lumen [11]."
bp(GO:"lysosomal microautophagy") -> tloc(a(GO:cytoplasm),fromLoc(GO:intracellular),toLoc(GO:lysosome))
bp(GO:"chaperone-mediated autophagy") -> tloc(a(MESH:Proteins),fromLoc(GO:cytoplasm),toLoc(GO:"lysosomal lumen"))

SET Evidence = "These processes are distinguished from
macroautophagy, in which an isolation membrane expands to engulf a portion of the cell,
eventually fusing to form a new autophagic vacuole that subsequently fuses with a lysosome [12]."
bp(GO:macroautophagy) -> bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "Even within the category of macroautophagy, there appears to be capability for selectivity,
as autophagic processes have been observed that appear to be specific for mitochondria
(mitophagy), portions of the nucleus (nucleophagy), peroxisomes (pexophagy), endoplasmic
reticulum (reticulophagy), microorganisms (xenophagy), ribosomes (ribophagy) or protein
aggregates (aggrephagy) (reviewed in [5])."
bp(GO:mitophagy) isA bp(GO:macroautophagy)
bp(GO:"autophagy of nucleus") isA bp(GO:macroautophagy)
bp(GO:pexophagy) isA bp(GO:macroautophagy)
bp(GO:reticulophagy) isA bp(GO:macroautophagy)
bp(GO:xenophagy) isA bp(GO:macroautophagy)
bp(GO:ribophagy) isA bp(GO:macroautophagy)
bp(GO:aggrephagy) isA bp(GO:macroautophagy)

SET Evidence = "CMA is a process in which proteins
harboring a pentapeptide motif related to the sequence KFERQ are specifically recognized by
a cytosolic chaperone, the heat shock cognate protein of 70 kDa (hsc70)."
p(HGNC:HSPA8) -> complex(p(HGNC:HSPA8),a(MESH:Proteins))
p(HGNC:HSPA8) -> complex(p(HGNC:HSPA8),a(MESH:Proteins)) -> bp(GO:"chaperone-mediated autophagy")

SET Evidence = "The substrate-chaperone
complex is then targeted to the lysosome by binding to lysosome-associated
membrane protein 2A (LAMP-2A) which carries out receptor-mediated translocation of the
substrate into the lysosome for degradation [11,13]"
p(HGNC:HSPA8) -> complex(p(HGNC:HSPA8),a(MESH:Proteins)) -> complex(p(HGNC:HSPA8),a(MESH:Proteins),p(HGNC:LAMP2))
p(HGNC:LAMP2) -> tloc(a(MESH:Proteins),fromLoc(GO:intracellular),toLoc(GO:lysosome))
tloc(a(MESH:Proteins),fromLoc(GO:intracellular),toLoc(GO:lysosome)) -> deg(a(MESH:Proteins))

SET Evidence = "The initial step in autophagy involves expansion of a membranous structure called the
“isolation membrane” or “phagophore” that engulfs a portion of the cell; the membrane
eventually fuses to form a new double-membraned structure known as an autophagosome (Figure 1)."
a(GO:phagophore) -> a(GO:autophagosome)
a(GO:autophagosome) -> bp(GO:autophagy)

SET Evidence = "The process of autophagy is controlled by parallel activation cascades that involve
ubiquitin-like (UBL) protein modification, strikingly similar to the activation cascade that
regulates the UPS (Figure 2a)."
bp(GO:"protein ubiquitination") reg bp(GO:autophagy)

SET Evidence = "In the first arm of the Atg conjugation system, phagophore
membrane elongation is triggered through the sequential action of an E1-like protein (Atg7)
and an E2-like protein (Atg10) leading to an isopeptide linkage between the C-terminal glycine
the UBL protein Atg12 and a lysine residue of Atg5 (Figure 2b)."
composite(p(HGNC:ATG7),p(HGNC:ATG10)) -> complex(p(HGNC:ATG12),p(HGNC:ATG5))
composite(p(HGNC:ATG7),p(HGNC:ATG10))  -> a(GO:phagophore)

SET Evidence = "These Atg12-Atg5 conjugates
are further cross-linked to Atg16 to form a large (~350 kDa) multimeric complex, which has
been thought to act as a structural support for membrane expansion [15]."
complex(p(HGNC:ATG12),p(HGNC:ATG5)) -> complex(p(HGNC:ATG12),p(HGNC:ATG5),p(HGNC:ATG16L1))
complex(p(HGNC:ATG12),p(HGNC:ATG5),p(HGNC:ATG16L1)) -> a(GO:phagophore)

SET Evidence = "More recent work has demonstrated that the Atg12-Atg5 conjugate can function as an E3-like enzyme in the
second arm of the Atg conjugation cascade to promote lipidation of Atg8 [16]"
complex(p(HGNC:ATG12),p(HGNC:ATG5)) -> p(HGNC:GABARAPL2,pmod(GO:"protein lipidation"))

SET Evidence = "In a second arm of the Atg conjugation system, Atg4 cleaves the UBL protein
Atg8 to promote interaction with Atg7."
p(HGNC:ATG4A) -> p(HGNC:GABARAPL2,frag("?"))
p(HGNC:ATG4A) -> complex(p(HGNC:ATG4A),p(HGNC:ATG7))

SET Evidence = "Atg8 is then conjugated with the phospholipid phosphotidylethanolamine (PE) by the
concerted action of the E2-like Atg3 and the E3-like Atg12-Atg5 conjugate"
# then: after cleavage
composite(p(HGNC:ATG12),p(HGNC:ATG5),p(HGNC:ATG3)) -> complex(p(HGNC:GABARAPL2,frag("?")),a(CHEBI:phosphatidylethanolamine))

SET Evidence = "Once formed, new autophagosomes move through a stepwise maturation process that
culminates with fusion to a lysosome permitting degradation of the lumenal contents."
a(GO:autophagosome) -> bp(GO:"autophagosome-lysosome fusion")
bp(GO:"autophagosome-lysosome fusion") -> bp(GO:"protein catabolic process")

SET Evidence = "In mammals, autophagosomes first fuse with endosomes and multivesicular bodies to form
amphisomes, which subsequently fuse with lysosomes to create degradative vacuoles termed
autolysosomes [17]."
a(GO:autophagosome) -> complex(a(GO:endosome),a(GO:autophagosome),a(GO:"multivesicular body"))
complex(a(GO:endosome),a(GO:autophagosome),a(GO:"multivesicular body")) -> a(GO:amphisome)
a(GO:amphisome) -> complex(a(GO:amphisome),a(GO:lysosome))
complex(a(GO:amphisome),a(GO:lysosome)) -> a(GO:autolysosome)

SET Evidence = "While GABARAP and GATE-16 may also be conjugated to PE in experimental systems, at present MAP-LC3
(typically abbreviated LC3) is the only protein that is known to remain associated with the
autophagosome in higher eukaryotes."
p(HGNC:MAP1LC3B) -> complex(p(HGNC:MAP1LC3B),a(GO:autophagosome))
p(HGNC:GABARAP) -> complex(p(HGNC:GABARAP),a(CHEBI:phosphatidylethanolamine))
p(HGNC:GABARAPL2) -> complex(p(HGNC:GABARAPL2),a(CHEBI:phosphatidylethanolamine))

SET Evidence = "LC3-I becomes conjugated to PE to form “LC3-II” and thereby
covalently associates with the phagophore"
p(HGNC:MAP1LC3B) -> complex(p(HGNC:MAP1LC3B),a(CHEBI:phosphatidylethanolamine))
complex(p(HGNC:MAP1LC3B),a(CHEBI:phosphatidylethanolamine)) -> complex(p(HGNC:MAP1LC3B),a(CHEBI:phosphatidylethanolamine),a(GO:phagophore))

SET Evidence = "LC3-II staining is also used as
a primary histological marker of autophagosomes."
complex(p(HGNC:MAP1LC3B),a(CHEBI:phosphatidylethanolamine)) -- a(GO:autophagosome)

SET Evidence = "Many neurodegenerative diseases are characterized by accumulation of misfolded protein
deposits in affected brain regions, suggesting a failure in the cell’s degradative capacity [19]."
SET MeSHAnatomy = "Brain"
path(MESH:"Neurodegenerative Diseases") pos p(MESH:Proteins,pmod(HBP:misfolding))
UNSET MeSHAnatomy

SET Evidence = "Indeed, experimental evidence indicates that neurodegeneration
is frequently associated with impaired UPS function, although whether this is a cause or
consequence of neurodegeneration is a contested issue, as is reviewed elsewhere in this special issue"
path(HBP:Neurodegeneration) neg bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process")

SET Evidence = "It has also been suggested that autophagy plays a role in the initiation or progression of
some neurodegenerative diseases [20]."
bp(GO:autophagy) -- path(MESH:"Neurodegenerative Diseases")

SET Evidence = "This suggestion originates from the observed
accumulation of autophagic vacuoles in neurons from affected brain regions in a number of
neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Creutzfeldt-
Jakob disease, and many of the polyglutamine diseases [21–24]."
SET MeSHAnatomy = "Neurons"
a(GO:autophagosome) pos path(MESH:"Alzheimer Disease")
a(GO:autophagosome) pos path(MESH:"Parkinson Disease")
a(GO:autophagosome) pos path(MESH:"Creutzfeldt-Jakob Syndrome")
UNSET MeSHAnatomy

SET Evidence = "Alzheimer’s disease pathology features massive accumulation of autophagic vacuoles within large
swellings along dystrophic and degenerating neurites in neocortical and hippocampal pyramidal neurons [21]."
SET MeSHAnatomy = {"Neurites","Pyramidal Cells","Hippocampus","Neocortex"}
a(GO:autophagosome) pos path(MESH:"Alzheimer Disease")
UNSET MeSHAnatomy

SET Evidence = "In Huntington’s disease, affected neurons show accumulation of
huntingtin in cathepsin-D-positive vacuoles [24]. Cathepsin-D is a lysosomal protease enriched
in neuronal tissues, suggesting that these are autolysosomes"
path(MESH:"Huntington Disease") pos a(GO:autolysosome)

SET Evidence = "Insight into the role of autophagy in neurodegeneration has been provided by studies indicating that: 1) some
neurodegenerative disease-related proteins are degraded by autophagy, 2) impairment of
autophagy promotes neurodegeneration in animal models and several human
neurodegenerative diseases, and 3) manipulation of autophagy modifies phenotypes in animal models of neurodegeneration."
path(MESH:"Neurodegenerative Diseases") neg bp(GO:autophagy)

SET Evidence = "That neurodegenerative disease-causing proteins are frequently degraded by autophagy was
demonstrated by a series of in vitro studies which showed that pharmacological induction or
inhibition of macroautophagy alters the rate of turnover of a number of disease-related proteins
including polyglutamine-expanded proteins, polyalanine-expanded proteins, as well as wild
type and mutant forms of α-synuclein [25,26]"
bp(GO:autophagy) -> deg(p(HGNC:SNCA))
bp(GO:autophagy) -> deg(p(HGNC:SNCA,var("?")))

SET Evidence = "CMA has also been found to contribute to the degradation of α-synuclein [29]."
bp(GO:"chaperone-mediated autophagy") -> deg(p(HGNC:SNCA))

SET Evidence = "In the case of α-synuclein, for example, Webb et
al. concluded that soluble forms of the disease protein are efficiently degraded by the UPS,
while aggregated or oligomeric α-synuclein require autophagy for clearance [26]."
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -> deg(p(HGNC:SNCA))
bp(GO:autophagy) -> a(HBP:"alpha-synuclein aggregates")
bp(GO:autophagy) -> a(HBP:"alpha-synuclein oligomers")

SET Evidence = "It is becoming increasingly evident that the autophagy-lysosomal system is essential to
neuronal homeostasis, and may in some settings be neuroprotective"
bp(GO:autophagy) reg bp(GO:"neuron cellular homeostasis")
bp(GO:autophagy) -| path(HBP:Neurodegeneration)

SET Evidence = "The consequences of impaired lysosome function, for example, may be observed in cathepsin D knockout mice and
Drosophila melanogaster cathepsin D mutants which show neurodegeneration and associated
accumulation of autophagosomes and lysosomes [33–35]."
p(HGNC:CTSD) -| path(HBP:Neurodegeneration)
p(HGNC:CTSD) neg a(GO:lysosome)
p(HGNC:CTSD) neg a(GO:autophagosome)

SET Evidence = "Indeed, primary lysosomal dysfunction in inherited congenital “lysosomal storage disorders” has long
been recognized to cause severe neurodegenerative phenotypes characterized pathologically
by accumulations of lysosomes and autophagic vacuoles [38]"
act(a(GO:lysosome)) -| path(HBP:Neurodegeneration)
act(a(GO:lysosome)) -> a(GO:autophagosome)
act(a(GO:lysosome)) -> a(GO:lysosome)

SET Evidence = "For example, the neuronal ceroid
lipofuscinoses (NCLs) are a heterogeneous group of inherited, neurodegenerative disorders
with onset ranging from infancy to late adulthood that are caused by a variety of defects in
lysosomal function."
act(a(GO:lysosome)) neg path(MESH:"Neuronal Ceroid-Lipofuscinoses")

SET Evidence = "Mutations in CLN3, a transmembrane protein that localizes to
the late endosomal/lysosomal membrane, cause a form of NCL"
p(HGNC:CLN3,var("?")) -> path(MESH:"Neuronal Ceroid-Lipofuscinoses")

SET Evidence = "CLN3-related neurodegeneration appears to be a consequence of reduced autophagosome-lysosome fusion [42]."
a(GO:autolysosome) -| path(HBP:Neurodegeneration)

SET Evidence = "Diseasecausing mutations in ATP13A2 result in protein retention in the endoplasmic reticulum and
enhanced proteasomal degradation, suggesting that neurodegeneration could be caused by
overwhelming the UPS and/or loss of function in lysosomal protein degradation [39]."
p(HGNC:ATP13A2,var("?")) -> bp(GO:"proteasomal protein catabolic process")
p(HGNC:ATP13A2,var("?")) -> path(HBP:Neurodegeneration)

SET Evidence = "Rab7 participates in trafficking autophagosomes and fusion with lysosomes and disease-causing
mutations are predicted to impair this process [43–45]."
p(HGNC:RAB7A) -> bp(GO:"autophagosome-lysosome fusion")
p(HGNC:RAB7A,var("?")) -| bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "Microtubule-based vesicular
trafficking is essential for delivery of autophagosomes to lysosomes and subsequent fusion
[46], and impaired dynein-mediated trafficking is associated with impaired autophagosome/
lysosome fusion and reduced protein turnover [47,48]."
a(GO:microtubule) -> bp(GO:"autophagosome-lysosome fusion")
a(MESH:Dyneins) -> bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "Indeed, a mouse model of distal-SBMA that expresses mutant p150/dynactin is characterized by
accumulation of ubiquitin-positive aggregates and autophagic vacuoles in affected neurons [49]."
p(HGNC:DCTN1,var("?")) pos a(GO:autophagosome)

SET Evidence = "For example, in a Drosophila model of X-linked spinobulbar
muscular atrophy (SBMA), a polyglutamine disease, degeneration was strongly enhanced by
genetic inhibition of autophagy [50]."
bp(GO:autophagy) neg path(MESH:"Bulbo-Spinal Atrophy, X-Linked")

SET Evidence = "Similarly, in transgenic mice expressing amyloid
precursor protein, a mouse model of Alzheimer’s disease, genetic inhibition of autophagy by
heterozygous depletion of beclin-1 results in enhancement of neurodegeneration [51]."
SET MeSHDisease = "Alzheimer Disease"
bp(GO:autophagy) -| path(HBP:Neurodegeneration)
UNSET MeSHDisease

SET Evidence = "Pharmacological upregulation of autophagy can be
accomplished using the drug rapamycin, which works by inhibiting TOR (target of rapamycin),
a pleiotropic molecule that negatively regulates autophagy, among other functions"
a(CHEBI:sirolimus) -| act(p(HGNC:MTOR))
a(CHEBI:sirolimus) -> bp(GO:autophagy)

SET Evidence = "Indeed, treatment with rapamycin ameliorates the degenerative phenotype in a Drosophila model of
SBMA, as well as in Drosophila and mouse models of Huntington’s disease [48,50,52]."
a(CHEBI:sirolimus) -| path(MESH:"Bulbo-Spinal Atrophy, X-Linked")
a(CHEBI:sirolimus) -| path(MESH:"Huntington Disease")

SET Evidence = "In addition, inducing autophagy in an TOR-independent manner using lithium [53] or trehalose
[54–56] has been shown to accelerate clearance of disease proteins in vitro [56] and protect
against neurodegeneration in mouse and Drosophila models of Huntington’s disease [53,54]."
SET MeSHDisease = "Huntington Disease"
a(CHEBI:"lithium(1+)") -> bp(GO:autophagy)
a(CHEBI:"lithium(1+)") -| path(HBP:Neurodegeneration)
a(CHEBI:"alpha,alpha-trehalose") -> bp(GO:autophagy)
a(CHEBI:"alpha,alpha-trehalose") -| path(HBP:Neurodegeneration)
UNSET MeSHDisease

SET Evidence = "There have been fewer efforts to manipulate UPS
function for therapeutic benefit in neurodegenerative disease, but it was recently shown that
use of a proteasome activator enhanced survival in an in vitro model of Huntington’s disease
[58], suggesting that augmenting other routes of protein degradation may also provide
neuroprotection."
SET MeSHDisease = "Huntington Disease"
act(complex(GO:"proteasome complex")) -| path(HBP:Neurodegeneration)
UNSET MeSHDisease

SET Evidence = "For example, α-synuclein is degraded at least in part by CMA [29]."
bp(GO:"chaperone-mediated autophagy") -> deg(p(HGNC:SNCA))

SET Evidence = "Mutations in α-synuclein that
are causative of familial Parkinson’s disease are poorly transferred to the lysosomal lumen and
accumulate on the lysosomal surface, resulting in blockade of receptor-mediated translocation."
p(HGNC:SNCA,var("?")) -> path(MESH:"Parkinson Disease")
p(HGNC:SNCA,var("?")) -| tloc(p(HGNC:SNCA,var("?")),fromLoc(GO:cytoplasm),toLoc(GO:"lysosomal lumen")))

SET Evidence = "Several lines of evidence
suggest that there is an impairment of autophagy resulting from impaired autophagosome-lysosome
fusion combined with decreasing efficiency of the lysosomal system [60]."
# with regard to Alzheimer's Disease
SET MeSHDisease = "Alzheimer Disease"
bp(GO:"autophagosome-lysosome fusion") -> bp(GO:autophagy)
UNSET MeSHDisease

SET Evidence = "Recent evidence suggests that the autophagic turnover of amyloid beta precursor protein (APP) may underlie
the generation of toxic amyloid-β species [61]."
a(CHEBI:"amyloid-beta") -- deg(p(HGNC:APP))
bp(GO:autophagy) -> deg(p(HGNC:APP))

SET Evidence = "This view was initially challenged by the observation that
monoubiquitination operates as a key signal in endocytosis, a process important for numerous
cell functions including lysosomal biogenesis [62]"
bp(GO:"protein monoubiquitination") -> bp(GO:endocytosis)
bp(GO:endocytosis) -> a(GO:lysosome)

SET Evidence = "The neuronal protein α-synuclein, for example, can be degraded by the UPS, macroautophagy and
chaperone-mediated autophagy [26,29]."
bp(GO:"chaperone-mediated autophagy") -> deg(p(HGNC:SNCA))
bp(GO:macroautophagy) -> deg(p(HGNC:SNCA))
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -> deg(p(HGNC:SNCA))

SET Evidence = "As mentioned above, dramatic illustration of the
interrelatedness of the UPS and autophagy was provided by characterizations of mice with
conditional knockout of the essential autophagy genes Atg5 or Atg7 in the central nervous
system, which resulted in neurodegeneration with accumulation of ubiquitin-positive
pathology [36,37]."
p(HGNC:ATG5) -| path(HBP:Neurodegeneration)
p(HGNC:ATG7) -| path(HBP:Neurodegeneration)

SET Evidence = "This model is consistent with an older study showing that inactivation of the
ubiquitin-activating enzyme E1 leads to a defect in autolysosomal degradation and to an
absence of ubiquitin-positive proteins within lysosomes [68]."
p(HGNC:UBA1) -> bp(GO:autophagy)
p(HGNC:UBA1) -> bp(GO:"protein ubiquitination")

SET Evidence = "It has been inferred that aggresome formation in vitro is a cytoprotective response in cultured cells since
their formation correlates inversely with cell death, whereas interventions that block aggresome
formation enhance cytotoxicity and slow the rate of turnover of misfolded proteins [27,64,70–72]"
a(GO:aggresome) neg bp(GO:"cell death")

SET Evidence = "It has now been established that
clearance of misfolded proteins from aggresomes is mediated at least in part by autophagy,
implicating this pathway as a compensatory mechanism for degrading misfolded proteins when
the proteasome is impaired [27,64,71,73]."
bp(GO:autophagy) reg deg(p(MESH:Proteins,pmod(HBP:misfolding)))

SET Evidence = "In addition to aggresome formation, impairment of the UPS in vitro has been found to induce
autophagy [63,64]."
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") neg bp(GO:autophagy)

SET Evidence = "Similar induction of autophagy is observed in response to genetic impairment of the proteasome
in Drosophila [50]."
act(complex(GO:"proteasome complex")) neg bp(GO:autophagy)

SET Evidence = "Similar results have recently been observed in vitro using the proteasome inhibitor lactacystin,
as pre-treatment with rapamycin attenuates lactacystin-induced apoptosis and reduces
lactacystin-induced ubiquitinated protein aggregation [74]."
composite(a(CHEBI:lactacystin),a(CHEBI:sirolimus)) -| bp(GO:"apoptotic process")
composite(a(CHEBI:lactacystin),a(CHEBI:sirolimus)) -| p(MESH:Proteins,pmod(ubiquitination))

SET Evidence = "Although the mechanism whereby autophagy and UPS function are coordinated is little
understood, several regulators have emerged as important players in mediating this crosstalk,
including histone deacetylase 6 (HDAC6) [50,64,75], p62/sequestosome 1 (p62) [76], and the
FYVE-domain containing protein Alfy [77]; notably, these proteins have all been found to
regulate or be essential for aggresome formation"
p(HGNC:HDAC6) reg bp(GO:autophagy)
p(HGNC:HDAC6) reg bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process")
p(HGNC:HDAC6) reg a(GO:aggresome)
p(HGNC:SQSTM1) reg bp(GO:autophagy)
p(HGNC:SQSTM1) reg bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process")
p(HGNC:SQSTM1) reg a(GO:aggresome)
p(HGNC:WDFY3) reg bp(GO:autophagy)
p(HGNC:WDFY3) reg bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process")
p(HGNC:WDFY3) reg a(GO:aggresome)

SET Evidence = "HDAC6 activity
appears to be important for trafficking ubiquitinated proteins and lysosomes in vitro and this
has led to the suggestion that HDAC6 coordinates delivery of substrates to autophagic
machinery [64,70,78]."
p(HGNC:HDAC6) -> tloc(p(MESH:Proteins,pmod(ubiquitination)),fromLoc(GO:cytoplasm),toLoc(GO:lysosome))

SET Evidence = "HDAC6 activity was also reported to regulate chaperone expression in
response to heat shock by deacetylating Hsp90 leading to release and activation of the
transcription factor HSF-1 [79]."
p(HGNC:HDAC6) -> bp(GO:"Hsp90 deacetylation")
p(HGNC:HDAC6)  reg complex(GO:"chaperone complex")
bp(GO:"Hsp90 deacetylation") -> act(p(HGNC:HSF1))

SET Evidence = "Cellular stresses such as polyQ
expression, proteasome impairment, oxidative stress, and increased misfolded protein burden
activate transcription and translation of p62, suggesting that it functions broadly in stress
situations [83,84]"
bp(GO:"cellular response to stress") -> p(HGNC:SQSTM1)
bp(GO:"response to oxidative stress") -> p(HGNC:SQSTM1)
p(MESH:Proteins,pmod(HBP:misfolding)) -> p(HGNC:SQSTM1)
act(complex(GO:"proteasome complex")) -| p(HGNC:SQSTM1)

SET Evidence = "p62 localizes to a variety of ubiquitin-positive neuropathological inclusions
including Lewy bodies in Parkinson’s disease, neurofibrillary tangles in tauopathies,
polyglutamine-expanded huntingtin aggregates in Huntington’s disease, and aggregates of
mutant SOD1 in familial amyotrophic lateral sclerosis [85–87]."
SET MeSHDisease = "Parkinson Disease"
p(HGNC:SQSTM1) -- a(GO:"Lewy body")
SET MeSHDisease = "Alzheimer Disease"
p(HGNC:SQSTM1) -- a(GO:"neurofibrillary tangle")
SET MeSHDisease = "Amyotrophic Lateral Sclerosis"
p(HGNC:SQSTM1) -- p(HGNC:SOD1,var("?"))
UNSET MeSHDisease

SET Evidence = "Thus, it has been suggested that p62 provides a key link
between autophagy and the UPS by facilitating autophagic degradation of ubiquitinated
proteins."
p(HGNC:SQSTM1) -> bp(GO:autophagy)
p(HGNC:SQSTM1) -> deg(p(MESH:Proteins,pmod(ubiquitination)))
p(HGNC:SQSTM1) -> bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process")

SET Evidence = "Recent models propose that p62 and HDAC6 function analogously to
facilitate autophagic degradation of proteins that display specific polyubiquitin topology."
p(HGNC:SQSTM1) -> bp(GO:autophagy)
p(HGNC:SQSTM1) -> bp(GO:"ubiquitin-dependent protein catabolic process")
p(HGNC:HDAC6) -> bp(GO:autophagy)
p(HGNC:HDAC6) -> bp(GO:"ubiquitin-dependent protein catabolic process")

SET Evidence = "Specifically, it is suggested that K63-linked polyubiquitin chains recruit p62 and
HDAC6 providing a signal for autophagic degradation [92,93]."
bp(GO:"protein K63-linked ubiquitination") -> act(p(HGNC:SQSTM1))
bp(GO:"protein K63-linked ubiquitination") -> act(p(HGNC:HDAC6))
bp(GO:"protein K63-linked ubiquitination") -> bp(GO:autophagy)

SET Evidence = "In cells that are exposed
to stressors such as starvation or UPS inhibition, Alfy relocalizes from the nuclear envelope
to filamentous cytoplasmic structures that are near autophagic membranes and ubiquitinated
protein inclusions, as well as within autophagosomes [77]."
path(MESH:Starvation) -> tloc(p(HGNC:WDFY3),fromLoc(GO:nucleus),toLoc(GO:cytoplasm))
bp(GO:"proteasome-mediated ubiquitin-dependent protein catabolic process") -| tloc(p(HGNC:WDFY3),fromLoc(GO:nucleus),toLoc(GO:cytoplasm))
tloc(p(HGNC:WDFY3),fromLoc(GO:nucleus),toLoc(GO:cytoplasm)) -> bp(GO:"protein ubiquitination")

SET Evidence = "Mutations in blue cheese, the
Drosophila homology of human Alfy, lead to reduced longevity and the accumulation of
ubiquitinated neural aggregates, suggesting that its role in autophagic degradation may be
involved in the clearance of ubiquitin aggregates [77,94]"
p(HGNC:WDFY3) -> bp(GO:"ubiquitin-dependent protein catabolic process")
